Eugenix Biotech Private Limited

Eugenix Biotech Private Limited - healthcare in New Delhi, Delhi, India. Directors, charges & compliance details.
CIN U85100DL2014PTC272572 Incorporated 17 October 2014 ROC Delhi HQ New Delhi, Delhi, India
Converted to LLP Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹12.62 Lakh
▲ 25% YoY
Net profit · FY 2025
₹4.39 Lakh
Net margin 34.8%
EBITDA · FY 2025
₹6.25 Lakh
EBITDA margin 49.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹27.47 Lakh
No open charges
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings

About Eugenix Biotech Private Limited

Data last updated:

Eugenix Biotech Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the hospital and clinical services segment of the healthcare sector. It was incorporated on 17 October 2014.

The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2014PTC272572. Its GSTIN is 07AAFCD1489C1ZT (Delhi). The company held 4 GST registrations, of which 1 is active.

The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Dermis Health Private Limited. It was led by directors Arika Bansal and Pradeep Kumar Sethi.

Its last annual general meeting (AGM) was held on 16 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Plot No.162A 3rd Floor Main Road, Palam Extn Sec – 7 Dwarka, New Delhi, Delhi, India – 110077.

As per the financials filed for FY 2025, the company reported a revenue of ₹12.62 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹4.39 Lakh (net margin 34.8%) and EBITDA of ₹6.25 Lakh (EBITDA margin 49.5%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 43% over five years.

As per MCA filings, the company has satisfied charges of ₹27.47 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.

Company details

CIN U85100DL2014PTC272572
Registration Number 272572
Incorporation Date 17 October 2014
ROC Delhi
Listing Status Unlisted
Company Status Converted to LLP
Date of Last AGM 16 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Eugenix Biotech Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No.162A 3rd Floor Main Road, Palam Extn Sec – 7 Dwarka, New Delhi, Delhi, India – 110077
  • Industry
    Healthcare, Hospitals

To see the full contact details of Eugenix Biotech Private Limited, buy the company report.

Comprehensive company report
Eugenix Biotech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Eugenix Biotech is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

Financials of Eugenix Biotech Private Limited

FY 2025 filings available

Eugenix Biotech Private Limited reported revenue of ₹12.62 Lakh (up 25% YoY) for FY 2025.

Revenue · FY 2025
₹12.62 Lakh ▲ 25%
Net profit · FY 2025
₹4.39 Lakh margin 34.8%
EBITDA · FY 2025
₹6.25 Lakh margin 49.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 14%
5 years · compounded
▼ 43%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▲ 13%
5 years · compounded
▼ 37%

Revenue rose 25% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 43%. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.25 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.39 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin49.5%
Net Profit Margin34.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Eugenix Biotech Private Limited, buy the company report.

Board of directors of Eugenix Biotech Private Limited

Eugenix Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Arika BansalDirector01 May 201610 Years 5 MonthsAs last reported
Pradeep Kumar SethiDirector17 Oct 201412 Years 0 MonthsAs last reported

Peer comparison

Eugenix Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Indira Medicare and Wellness Private Limited₹12.68 Lakh (FY 2024)-12.0%Bengaluru, Karnataka, India
Ishan Hospital Intensive Care Private Limited₹12.63 Lakh (FY 2024)14.0%Delhi, India
Eugenix Biotech Private Limitedthis company₹12.62 Lakh (FY 2025)₹4.39 Lakh34.8%25.0%New Delhi, Delhi, India
Azuara Wellness Private Limited₹12.52 Lakh (FY 2021)Thane, Maharashtra, India

To see the full peer comparison of Eugenix Biotech Private Limited, buy the company report.

Auditor

Eugenix Biotech Private Limited is audited by Vivek Sanjay & Co Chartered Accountant for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Vivek Sanjay & Co Chartered AccountantFY 2023014189N

Shareholding

The shareholding of Eugenix Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Eugenix Biotech Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹27.47 Lakh
Breakdown by lending institutions
Hdfc Bank Limited₹0.27 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Dec 201510622145Hdfc Bank Limited₹27.47 LakhSatisfied

To see the full charge records of Eugenix Biotech Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Eugenix Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Eugenix Biotech has 4 GST registrations: 1 active and 3 cancelled or inactive.

Total GSTINs
4
Active
1
Cancelled / inactive
3
GSTINStateStatusRegistered on
07AAFCD1489C1ZTDelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Eugenix Biotech Private Limited, buy the company report.

Recent activity

Eugenix Biotech Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Sanatan Sethy ceased to be Director on 29 Jun 2016.

AGM
Eugenix Biotech Private Limited last Annual general meeting of members was held on 16 Aug 2025 as per latest MCA records.
Filing
Eugenix Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 28 Dec 2015 via Charge ID 10622145 with Hdfc Bank Limited was fully satisfied on 21 Mar 2024.
Ceased
Sanatan Sethy ceased to be Director.
Appointed
Arika Bansal was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 27.47 Lakh with Charge ID 10622145 was registered on 28 Dec 2015.
Appointed
Pradeep Kumar Sethi was appointed as Director.
Incorporation
17 Oct 2014
Eugenix Biotech Private Limited was registered on 17 Oct 2014 with Roc Delhi & aged 12 years 11 days as per MCA records.

Frequently asked questions

Eugenix Biotech has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.

Eugenix Biotech was a private limited company based in New Delhi, Delhi, India. The company worked in hospitals, within the healthcare industry. It was incorporated on 17 October 2014 and is registered under CIN U85100DL2014PTC272572. For the latest details, refer to the successor LLP entity.

The CIN (Corporate Identification Number) of Eugenix Biotech is U85100DL2014PTC272572. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Eugenix Biotech had 2 directors:

Eugenix Biotech was incorporated on 17 October 2014. It is registered with the Registrar of Companies, Delhi.

The registered office of Eugenix Biotech is at Plot No.162A 3rd Floor Main Road, Palam Extn Sec – 7 Dwarka, New Delhi, Delhi, India – 110077.

The latest financial statements of Eugenix Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 16 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Eugenix Biotech is 07AAFCD1489C1ZT, registered in Delhi. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.

Eugenix Biotech operated in the healthcare industry, in the hospitals segment.

The peers of Eugenix Biotech by revenue are Indira Medicare and Wellness Private Limited, Ishan Hospital Intensive Care Private Limited, Azuara Wellness Private Limited, all in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (other hospital and medical care activities).

Eugenix Biotech has 1 court case on record: 1 filed by the company.